Zeljko S. Radic, MD, Martin K. O'Donohoe, MB, FRCSI, Lewis B

Slides:



Advertisements
Similar presentations
Endothelial cell seeding reduces thrombogenicity of Dacron grafts in humans Per Örtenwall, MD, PhD *, Hans Wadenvik, MD, PhD **, Jack Kutti, MD, PhD **,
Advertisements

The role of arteriovenous shunts in the pathogenesis of varicose veins Howard C. Baron, M.D., Sebastiano Cassaro, M.D. Journal of Vascular Surgery Volume.
The effect of inguinal lymphatic manipulation on regional lymph flow patterns Jeffrey R. Rubin, MD, Lisa B. Eberlin, MD Journal of Vascular Surgery Volume.
Development and regression of intimal thickening of arterially transplanted autologous vein grafts in dogs  Kazumasa Morinaga, M.D., Hiroshi Eguchi, M.D.,
Quantitation of vascular outflow by measurement of impedance
Dipeptidyl peptidase 4 inhibitor reduces intimal hyperplasia in rabbit autologous jugular vein graft under poor distal runoff  Akio Koyama, MD, Kimihiro.
Mark F. Fillinger, MD, Emanuel R. Reinitz, MD, Robert A
Robert J. Pitsch, MD, David J. Minion, MD, Margaret L
Antisense oligonucleotide to proto-oncogene c-myb inhibits the formation of intimal hyperplasia in experimental vein grafts  Gregory J. Fulton, MB, FRCSI,
Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production 
Dose responsive suppression of myointimal hyperplasia by dexamethasone
Anti–VLA-4 antibody reduces intimal hyperplasia in the endarterectomized carotid artery in nonhuman primates  Alan B. Lumsden, MB, ChB, Changyi Chen,
Dipeptidyl peptidase 4 inhibitor reduces intimal hyperplasia in rabbit autologous jugular vein graft under poor distal runoff  Akio Koyama, MD, Kimihiro.
Atherosclerotic aneurysm formation in an in situ saphenous vein graft
Marilyn J. Cipolla, MS, Christian T. Harker, PhD, John M. Porter, MD 
A new valvulotome for in situ bypass grafts
Howard P. Greisler, MD, Joan Ellinger, Scott C. Henderson, Anne M
Alterations in wall tension and shear stress modulate tyrosine kinase signaling and wall remodeling in experimental vein grafts  Tam T.T. Huynh, MD, Mark.
Endothelium-dependent vasorelaxations in response to aggregating platelets are impaired in reversed vein grafts  Kimihiro Komori, MD, Peter Gloviczki,
Axillofemoral bypass: A tool with a limited role
Michael A. Golden, MD, Y. P. Tina Au, PhD, Richard D
Gregory D. Jay, BE, BS, Frank L. Ross, MD, Robert A
Malcolm O. Perry, MD, Richard Kempczinski, MD 
Adventitial endothelial implants reduce matrix metalloproteinase-2 expression and increase luminal diameter in porcine arteriovenous grafts  Helen M.
Nonporous silicone polymer coating of expanded polytetrafluoroethylene grafts reduces graft neointimal hyperplasia in dog and baboon models  Alan B. Lumsden,
William W. Lin, BA, Gregory S. McGee, MD, Bruce K
Local treatment with recombinant tissue factor pathway inhibitor reduces the development of intimal hyperplasia in experimental vein grafts  Tam T.T.
The temporal relationship between the development of vein graft intimal hyperplasia and growth factor gene expression  John R. Hoch, MD, Vida K. Stark,
Saphenous vein biopsy: A predictor of vein graft failure
Anton N. Sidawy, MD, Fares S. Hakim, MD, Bruce A. Jones, MD, Jose M
Bacterial resistance of refrigerated and cryopreserved aortic allografts in an experimental virulent infection model  Pierre-Yves Litzler, MD, Pascale.
Anti–VLA-4 antibody reduces intimal hyperplasia in the endarterectomized carotid artery in nonhuman primates  Alan B. Lumsden, MB, ChB, Changyi Chen,
Thrombolysis for experimental deep venous thrombosis maintains valvular competence and vasoreactivity  Jeffrey M. Rhodes, MD, Jae-Sung Cho, MD, Peter.
William Fiore, M. D. , Thomas E. Penn, M. D. , Timothy Quill, M. D
Photodynamic therapy of vein grafts: Suppression of intimal hyperplasia of the vein graft but not the anastomosis  Glenn M. LaMuraglia, MD, Michael L.
Axillary grafts for difficult hemodialysis access
Tissue concentrations of endothelins and functional effects of endothelin-receptor activation in human arteries and veins  Peter Holm, MD, Anders Franco-Cereceda,
Objective tinnitus resulting from internal carotid artery stenosis
Mark K. Hirko, MD, Joseph R. McShannic, MD, Steven P
Association of smooth muscle cell phenotypic modulation with extracellular matrix alterations during neointima formation in rabbit vein grafts  Wei-da.
Robert A. McCready, M. D. , Margaret A. Price, B. S. , Richard J
Mostafa N. El-Sanadiki, MB, MS, K. Simon Cross, MB, John J
Carotid endarterectomy with homologous vein patch angioplasty: A review of 1006 cases  Konstadinos A. Plestis, MD, George Kantis, MS, Kenneth Haygood,
Transarterial wall oxygen gradients at a prosthetic vascular graft to artery anastomosis in the rabbit  Steven M. Santilli, MD, PhD, Shane E. Wernsing,
Physiology of carotid endarterectomy with ocular pneumoplethysmography
The effect of carbon coating and porosity on early patency of expanded polytetrafluoroethylene grafts: An experimental study  Donald L. Akers, MD, Yong.
Boulos Toursarkissian, MD, David Schwartz, MD, PhD, Paul R
Diabetes mellitus and experimental vein graft structure and function
Functional analysis of cryopreserved veins
Immunosuppressive treatment of aortic allografts
Vein interposition cuffs decrease the intimal hyperplastic response of polytetrafluoroethylene bypass grafts  Mark Kissin, MD, Nikhil Kansal, MD, Peter.
Human saphenous vein allograft bypass grafts: Immune response
Calvin B. Ernst, MD  Journal of Vascular Surgery 
Cardiovascular surgery—The rocket and its stars: Presidential address
Composite sequential bypasses to the ankle and beyond for limb salvage
Research and research funding in vascular surgery
Joseph J. Piotrowski, MD, Glenn C. Hunter, MD, Cleamond D
Quantitation of vascular outflow by measurement of impedance
Argon laser—welded arteriovenous anastomoses
Stanley Ziomek, M. D. , William J. Quiñones-Baldrich, M. D. , Ronald W
Richard J. Sanders, MD 1, William H. Pearce, MD 2 
Monitoring vascular surgical performance
Glenn C. Hunter, M.D., Stan N. Carson, M.D. 
Hypercholesterolemia impairs endothelium-dependent relaxations to aggregating platelets in porcine iliac arteries  Kimihiro Komori, MD, Hiroaki Shimokawa,
D. Emerick Szilagyi, MD—An appreciation
Presidential address: The second-generation vascular surgeon
George D. Lilly 1906–1988 Journal of Vascular Surgery
James A. DeWeese, MD  Journal of Vascular Surgery 
Prevention of stenosis after vascular reconstruction: Pharmacologic control of intimal hyperplasia—A review  Alexander W. Clowes, MD, Michael A. Reidy,
Lessons learned in adopting the in situ saphenous vein bypass
Presentation transcript:

Alterations in serotonergic receptor expression in experimental vein grafts  Zeljko S. Radic, MD, Martin K. O'Donohoe, MB, FRCSI, Lewis B. Schwartz, MD, Adam D. Stein, MD, Eileen M. Mikat, PhD, Richard L. McCann, MD, Per-Otto Hagen, PhD  Journal of Vascular Surgery  Volume 14, Issue 1, Pages 40-47 (July 1991) DOI: 10.1016/0741-5214(91)90152-K Copyright © 1991 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

Fig. 1 Progressive intimal thickening of rabbit external jugular vein grafts harvested at 3 (A), 9 (B), 14 (C), and 28 (D) days. Sections are stained with Masson's trichrome and Verhoeff's elastic tissue stain. Significant intimal hyperplasia (IH) was observed as early as 1 week after implantation and continued to increase throughout the study period (original magnification × 66; L = lumen, I-M = intima + media, AD = adventitia). Journal of Vascular Surgery 1991 14, 40-47DOI: (10.1016/0741-5214(91)90152-K) Copyright © 1991 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

Fig. 2 Maximal tension to 5-HT (open circles) and % intimal area (open squares) in rabbit external jugular vein grafts harvested from 3 to 28 days. A total of 37 grafts were studied. Note the qualitative correlation between 5-HT response and percent intimal area. Numeric data are given in Tables I and II. Journal of Vascular Surgery 1991 14, 40-47DOI: (10.1016/0741-5214(91)90152-K) Copyright © 1991 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

Fig. 3 5-HT dose-response curves of 11 rabbit external jugular vein grafts explanted after 9 days. ED50 progressively increased with increasing doses of ketanserin. Numeric data and statistical analysis are given in Table III. Journal of Vascular Surgery 1991 14, 40-47DOI: (10.1016/0741-5214(91)90152-K) Copyright © 1991 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

Fig. 4 Response of precontracted rabbit external jugular vein to 5-HT. Addition of 5-HT to control veins (■) resulted in dose-dependent relaxation with maximum of 49% ± 10% at 1.7 × 10−7 mol/L. Incubation with ketanserin (▴) did not affect relaxation, whereas incubation with methiothepin (▾) completely abolished the relaxation response. Journal of Vascular Surgery 1991 14, 40-47DOI: (10.1016/0741-5214(91)90152-K) Copyright © 1991 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

Fig. 5 Response of precontracted vein graft to 5-HT. Addition of 5-HT (closed squares) resulted in dose-dependent contraction with a maximum of 322% ± 33% at 10−4 mol/L Incubation with 10−6 mol/L ketanserin (closed triangle) resulted in a significant increase in ED50 (control 9.75 ± 1.5 × 10−7 mol/L vs ketanserin 1 1 ± 0.2 × 10−4 mol/L, p < 0.002). Journal of Vascular Surgery 1991 14, 40-47DOI: (10.1016/0741-5214(91)90152-K) Copyright © 1991 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions